Organic Process Research & Development 2000, 4, 170−171
Efficient Large Scale Synthesis of 2′-O-Alkyl Pyrimidine Ribonucleosides
Saroj K. Roy*,† and Jin-yan Tang
Hybridon Inc., 155 Fortune BouleVard, Milford, Massachusetts 01757
Scheme 1
Abstract:
An efficient process to synthesize 2′-O-alkyl pyrimidine ribo-
nucleosides in high yield has been described. The inexpensive
method was used on a multikilogram-scale synthesis and
optimized reaction conditions have been investigated.
Results and Discussion
The presence of 2′-O-alkyl ribonucleosides in oligonucle-
otides has been shown both in vitro and in vivo to provide
a better stability and also strong binding capability to the
complementary gene targets. Particularly 2′-O-methyl modi-
fied nucleosides have been widely used in oligonucleotides
synthesis for the purpose of research and future therapeutic
application.1-3 Several 2′-O-methyl nucleoside modified
oligonucleotides are at present in clinical trials including the
antiangiogenic ribozyme molecule, RPI 4610.4
We require a large quantity of 2′-O-methyl uridine (10
kg) for phase II trials of GEM 231.5 2′-O-methyl uridine
has been prepared by using following two methods (Schemes
1 and 2). Scheme 1 would involve N3-protection by benzoyl
or toluyl, and 3′,5′-O-protected with TIPDSi-Cl ribonucleo-
sides have been subjected to alkylation of the ribose hydroxyl
group using methyl iodide and silver oxide.6-9 The overall
yield after deportation of N3 and 3′,5′-O-TIPDSi ribonucleo-
sides was 13%. The three purifications at intermediate level
made the process labor-intensive.
The second method also needed the 3′,5′-O-protection
with TIPDSi-Cl followed by Pummerer rearrangement. The
recovery of 6 after borohydride reduction and deportation
of 9 was 18% (Scheme 2). These methods thereby increase
Scheme 2
† Present address: PE Biosystems, 500 Old Connecticut Path, Framingham,
MA 01701.
(1) (a) Cummins, L.; Owens, S.; Risen, L.; Lesnik, E.; Freier, S.; McGee, D.;
Guinosso, C.; Dan Cook, P. Nucleic Acids Res. 1995, 23, 2019-2024. (b)
Lesnick, E.; Guinosso, C.; Kawasaki, A.; Sasmor, H.; Zounes, M.;
Cummins, L.; Ecker, D.; Dan Cook, P.; Freier, S. Biochemistry 1993, 32,
7832-7838. (c) Kawai, G.; Yamamoto, Y.; Kamimura, T.; Masegi, T.;
Sekine, M.; Hata, T.; Iimori, T.; Watanabe, T.; Miyazawa, T.; Yokoyama,
S. Biochemistry 1992, 31, 1040-1046. (d) Sproat B.; Lamond A.; Beijer
B.; Neuner P.; Ryder U. Nucleic Acids Res. 1989, 17, 3373-3386.
(2) Crooke, S. T., Lebleu, B., Eds. Antisense Research and Applications; CRC
Press: Boca Raton, Florida, 1993.
(3) (a) Goodchild, J. Nucleic Acids Res. 1992, 20, 4607-4612. (b) Agrawal,
S., Ed. Antisense Therapeutics; Humana Press: Totowa, New Jersey, 1996.
(4) Sandberg, J.; Bouhana, K.; Gallegos, A.; Agrawal, A.; Grimm, S.; Wincott,
F.; Reynolds, M.; Pavco, P.; Parry, T. Antisense Nucleic Acid Drug DeV.
1999, 9, 271-277.
the time and expense of synthesis while decreasing its
efficiency and overall yield. The poor recovery, expensive
reagents, and labor-intensive purification caused us to
investigate high-yielding, inexpensive, and practical method
amenable to a large-scale operation.
In this paper we report a simple, practical, and optimized
method for the synthesis of 6 in large scale. The synthesis
has been done in two steps via anhydronucleoside opening
by a nucleophile (Scheme 3). This method provides efficient
(5) Wang, H.; Cai, Q.; Zeng, X.; Yu, D.; Agrawal, S.; Zhang, R. Proc. Natl.
Acad. Sci. U.S.A. 1999, 96, 13989-13904.
(6) (a) Haines, A. Tetrahedron 1973, 29, 2807-2810. (b) Robins, M.; Naik,
S.; Lee, S. J. Org. Chem. 1974, 39, 1891-1899.
(7) Yamauchi, K.; Nakagima, T.; Kinoshita, M. J. Chem. Soc., Perkin Trans.
1 1980, 2787-2792.
Scheme 3
(8) Wagner, E.; Oberhauser, B.; Holzner, A.; Brunar, H.; Issakides, G.;
Schaffner, G.; Cotten, M.; Knollmuller, M.; Noe, C. Nucleic Acids Res.
1991, 19, 5965-5971.
(9) (a) Srivastva, S.; Roy, S. U.S. Patent 5,214,135, 1993. (b) Beijer, B.; Grotli,
M.; Douglas, M.; Sproat, B. Nucleosides Nucleotides 1994, 13, 1905-
1927. (c) Hodge, R.; Sinha, N. Tetrahedron Lett. 1995, 36, 2933-2936.
170
•
Vol. 4, No. 3, 2000 / Organic Process Research & Development
10.1021/op990100t CCC: $19.00 © 2000 American Chemical Society and The Royal Society of Chemistry
Published on Web 02/16/2000